Katsuichi Ohsawa
Direttore/Membro del Consiglio presso TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Posizioni attive di Katsuichi Ohsawa
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/06/2019 | - |
| Corporate Officer/Principal | 01/06/2019 | - | |
Taisho Pharmaceutical Co., Ltd.
 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/06/2019 | - |
| Corporate Officer/Principal | 01/04/2007 | - |
Storia della carriera di Katsuichi Ohsawa
Statistiche
Distribuzione geografica
| Giappone | 3 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Katsuichi Ohsawa
- Esperienza
